ARCHIVES

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science

October 28, 1994

Dole to Press HCFA On Community DRG Exemptions, Calls For Meeting TO Assess Problems

March 16, 1984

NCCN Guidelines Retain Avastin For Breast Cancer

October 22, 2010

Cigarette Smoking Linked With Cervical Cancer

April 13, 1984

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

Obituaries: Fritz Bach, 77, and William Wolff, 94

September 9, 2011